Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 06/01/2018 - 04/23/2021

Target Audience

This course is designed for pharmacists and/or other healthcare professionals involved in the medication management of individuals living with psychiatric, neurologic and/or substance use disorders.

Session Summary

Dr. Christopher M. Jones, Director of the National Mental Health and Substance Use Policy Laboratory, describes how the misuse of and addiction to opioids is a serious national problem that affects public health, as well as social and economic welfare. Jones will address the opioid crisis in the United States, the rising incidence of neonatal abstinence syndrome (due to opioid use during pregnancy), and the increased spread of infectious diseases, including HIV and hepatitis C. Primary approaches to addressing the crisis include prevention, addressing the underlying addiction issues, and treating overdoses directly by increasing access to naloxone. Longer-term research includes the development of pain medications with reduced abuse/addiction potential. In addition, the ways that pharmacists can play central roles in changing prescribing practices, increasing access to naloxone, and improving access to methadone and buprenorphine with pharmacy dispensing will be reviewed.

Read more about advancing the practice of pain management under the HHS Opioid Strategy.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)
Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at http://cpnp.org/mycpnp/transcript/acpe.

Faculty Information and Disclosures

Christopher M. Jones, PharmD, MPH

View biographical information and disclosures

Learning Objectives

  1. Describe the current opioid crisis in the United States.
  2. List primary approaches to resolving the crisis.
  3. Discuss long-term research approaches to resolving the crisis.
  4. Identify ways that pharmacists can be central to changing prescribing practices and increasing access to naloxone, methadone and buprenorphine.

Continuing Education Credit and Disclosures

Activity Dates: 06/01/2018 - 04/23/2021
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-18-024-H04-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 1.0 contact hour of knowledge-based continuing education credit from CPNP approved programming.